Hj. Kramer et al., ENDOGENOUS SODIUM-PUMP INHIBITORS IN HUMAN URINE - FURTHER IDENTIFICATION OF INHIBITORS OF NA-K-ATPASE, American journal of hypertension, 8(7), 1995, pp. 753-760
We investigated the presence of endogenous Na-K-ATPase inhibitor(s), i
e, ouabain-like factors (OLFs), in the urine of salt-loaded healthy su
bjects. For this purpose 24-h urine was collected on days 3, 4, and 5
of high sodium intake (>30 g NaCl/day). The samples then were lyophili
zed. Redissolved urine concentrates were acidified (pH 3.5) and subjec
ted to gelchromatography on a Sephadex G-25 column where the OLFs elut
ed in the post-salt fraction IV. When lyophilized fraction IV was rech
romatographed on Sephadex G-10, OLFs with molecular mass (M(r)) of app
roximately 400 eluted in a late fraction IV/8 separate from added ouab
ain, ouabagenin (or digoxin), which eluted shortly after void volume.
With the subsequent reverse-phase HPLC of fraction IV/8 a polar OLF-1
eluted in fraction IV/8a after the void volume in the water phase and
a more apolar OLF-2 eluted at 20% acetonitrile in fraction IV/8d. Only
the more apolar OLF-2 cross-reacted with a digoxin antibody. By prepa
rative thin-layer chromatography OLF-1 and OLF-2 were purified as sing
le compounds with potent dose-dependent Na-K-ATPase inhibition and K-i
-values approximating 1.5 x 10(-5) mol/L and 1.5 x 10(-4) mol/L, respe
ctively. Mass-spectroscopy (MS) showed M(r) of 391 and H-1-NMR charact
erized the endogenous urinary apolar OLF-2 as a compound that is struc
turally totally unrelated to ouabain; infrared (IR) spectroscopy of OL
F-1 and OLF-2 also revealed no similarity with ouabain. In contrast, d
ata from MS, NMR-, and IR-spectroscopy show structural resemblance wit
h ascorbic acid derivatives, some of these having strong inhibitory ef
fects on Na-K-ATPase.